Reflections on Model-Informed Drug Development

被引：0
|
作者：
Lesko, Lawrence J. [1 ]
van der Graaf, Piet H. [2 ,3 ]
机构：
[1] Univ Florida, Coll Pharm, Ctr Pharmacometr & Syst Pharmacol, Lake Nona, FL 32611 USA
[2] Certara, Appl BioSimulat, Canterbury, England
[3] Leiden Acad Ctr Drug Res, Leiden, Netherlands
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 116卷 / 02期
关键词：
D O I：
10.1002/cpt.3335
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：267 / 270
页数：4
相关论文
共 50 条
  • [41] Review: Role of Model-Informed Drug Development Approaches in the Lifecycle of Drug Development and Regulatory Decision-Making
    Madabushi, Rajanikanth
    Seo, Paul
    Zhao, Liang
    Tegenge, Million
    Zhu, Hao
    PHARMACEUTICAL RESEARCH, 2022, 39 (08) : 1669 - 1680
  • [42] Review: Role of Model-Informed Drug Development Approaches in the Lifecycle of Drug Development and Regulatory Decision-Making
    Rajanikanth Madabushi
    Paul Seo
    Liang Zhao
    Million Tegenge
    Hao Zhu
    Pharmaceutical Research, 2022, 39 : 1669 - 1680
  • [43] Optimizing the Dosing Regimen of Cetuximab and Ramucirumab Using the Model-Informed Drug Development Paradigm
    Ni, Lan
    Khan, Azhar Zaman
    Long, Amanda
    Gao, Ling
    Toms, Nikki
    Gonzalez-Gugel, Elena
    Holsmer-Brand, Susan
    Lin, Yong
    Abada, Paolo
    Dickin, Sandra
    O'Dea, Declan
    Wei, Ran
    Jen, Min-Hua
    Aggarwal, Himani
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (01) : 77 - 87
  • [44] Integrating Model-Informed Drug Development With AI: A Synergistic Approach to Accelerating Pharmaceutical Innovation
    Raman, Karthik
    Kumar, Rukmini
    Musante, Cynthia J.
    Madhavan, Subha
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (01):
  • [45] Model-Informed Pediatric Drug Development: Application of Pharmacometrics to Define the Right Dose for Children
    Vinks, Alexander A.
    Barrett, Jeffrey S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 : S52 - S59
  • [46] Cases studies of application of model-informed drug development in early phase clinical trials
    ZHAO Wei
    中国药理学与毒理学杂志, 2023, 37(S1) (S1) : 39 - 40
  • [47] Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting
    Kari M. Morrissey
    Mathilde Marchand
    Hina Patel
    Rong Zhang
    Benjamin Wu
    H. Phyllis Chan
    Almut Mecke
    Sandhya Girish
    Jin Y. Jin
    Helen R. Winter
    René Bruno
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 1257 - 1267
  • [48] Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting
    Morrissey, Kari M.
    Marchand, Mathilde
    Patel, Hina
    Zhang, Rong
    Wu, Benjamin
    Chan, H. Phyllis
    Mecke, Almut
    Girish, Sandhya
    Jin, Jin Y.
    Winter, Helen R.
    Bruno, Rene
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (06) : 1257 - 1267
  • [49] Model-Informed Drug Development and Review for Generic Products: Summary of FDA Public Workshop
    Fang, Lanyan
    Kim, Myong-Jin
    Li, Zhichuan
    Wang, Yaning
    DiLiberti, Charles E.
    Au, Jessie
    Hooker, Andrew
    Ducharme, Murray P.
    Lionberger, Robert
    Zhao, Liang
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (01) : 27 - 30
  • [50] Model-Informed Drug Development: Connecting the Dots With a Totality of Evidence Mindset to Advance Therapeutics
    Venkatakrishnan, Karthik
    van Der Graaf, Piet H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (05) : 1147 - 1154
12345